Literature DB >> 22078885

PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility.

Xinnan Wang1, Dominic Winter, Ghazaleh Ashrafi, Julia Schlehe, Yao Liang Wong, Dennis Selkoe, Sarah Rice, Judith Steen, Matthew J LaVoie, Thomas L Schwarz.   

Abstract

Cells keep their energy balance and avoid oxidative stress by regulating mitochondrial movement, distribution, and clearance. We report here that two Parkinson's disease proteins, the Ser/Thr kinase PINK1 and ubiquitin ligase Parkin, participate in this regulation by arresting mitochondrial movement. PINK1 phosphorylates Miro, a component of the primary motor/adaptor complex that anchors kinesin to the mitochondrial surface. The phosphorylation of Miro activates proteasomal degradation of Miro in a Parkin-dependent manner. Removal of Miro from the mitochondrion also detaches kinesin from its surface. By preventing mitochondrial movement, the PINK1/Parkin pathway may quarantine damaged mitochondria prior to their clearance. PINK1 has been shown to act upstream of Parkin, but the mechanism corresponding to this relationship has not been known. We propose that PINK1 phosphorylation of substrates triggers the subsequent action of Parkin and the proteasome.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078885      PMCID: PMC3261796          DOI: 10.1016/j.cell.2011.10.018

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  48 in total

1.  Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein.

Authors:  R Steven Stowers; Laura J Megeath; Jolanta Górska-Andrzejak; Ian A Meinertzhagen; Thomas L Schwarz
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

Review 2.  Moving mitochondria: establishing distribution of an essential organelle.

Authors:  Rebecca L Frederick; Janet M Shaw
Journal:  Traffic       Date:  2007-10-17       Impact factor: 6.215

3.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

4.  GRIF-1 and OIP106, members of a novel gene family of coiled-coil domain proteins: association in vivo and in vitro with kinesin.

Authors:  Kieran Brickley; Miriam J Smith; Mike Beck; F Anne Stephenson
Journal:  J Biol Chem       Date:  2005-01-11       Impact factor: 5.157

5.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

6.  Targeted ablation of CCAP neuropeptide-containing neurons of Drosophila causes specific defects in execution and circadian timing of ecdysis behavior.

Authors:  Jae H Park; Andrew J Schroeder; Charlotte Helfrich-Förster; F Rob Jackson; John Ewer
Journal:  Development       Date:  2003-06       Impact factor: 6.868

7.  Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.

Authors:  Matthew S Goldberg; Sheila M Fleming; James J Palacino; Carlos Cepeda; Hoa A Lam; Anushree Bhatnagar; Edward G Meloni; Nanping Wu; Larry C Ackerson; Gloria J Klapstein; Mahadevan Gajendiran; Bryan L Roth; Marie-Francoise Chesselet; Nigel T Maidment; Michael S Levine; Jie Shen
Journal:  J Biol Chem       Date:  2003-08-20       Impact factor: 5.157

8.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

9.  Mitochondrial dysfunction and oxidative damage in parkin-deficient mice.

Authors:  James J Palacino; Dijana Sagi; Matthew S Goldberg; Stefan Krauss; Claudia Motz; Maik Wacker; Joachim Klose; Jie Shen
Journal:  J Biol Chem       Date:  2004-02-24       Impact factor: 5.157

10.  Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Authors:  Enza Maria Valente; Patrick M Abou-Sleiman; Viviana Caputo; Miratul M K Muqit; Kirsten Harvey; Suzana Gispert; Zeeshan Ali; Domenico Del Turco; Anna Rita Bentivoglio; Daniel G Healy; Alberto Albanese; Robert Nussbaum; Rafael González-Maldonado; Thomas Deller; Sergio Salvi; Pietro Cortelli; William P Gilks; David S Latchman; Robert J Harvey; Bruno Dallapiccola; Georg Auburger; Nicholas W Wood
Journal:  Science       Date:  2004-04-15       Impact factor: 47.728

View more
  521 in total

Review 1.  The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

Review 2.  Regulation of autophagy by protein post-translational modification.

Authors:  Willayat Yousuf Wani; Michaël Boyer-Guittaut; Matthew Dodson; John Chatham; Victor Darley-Usmar; Jianhua Zhang
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

3.  Organelle dynamics. Stopping mitochondria in their tracks.

Authors:  Katharine H Wrighton
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-07       Impact factor: 94.444

Review 4.  Regulation of Parkin E3 ubiquitin ligase activity.

Authors:  Helen Walden; R Julio Martinez-Torres
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

Review 5.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 6.  Regulation of autophagy and mitophagy by nutrient availability and acetylation.

Authors:  Bradley R Webster; Iain Scott; Javier Traba; Kim Han; Michael N Sack
Journal:  Biochim Biophys Acta       Date:  2014-02-11

Review 7.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

8.  Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy.

Authors:  Tanveer Ahmad; Shravani Mukherjee; Bijay Pattnaik; Manish Kumar; Suchita Singh; Manish Kumar; Rakhshinda Rehman; Brijendra K Tiwari; Kumar A Jha; Amruta P Barhanpurkar; Mohan R Wani; Soumya S Roy; Ulaganathan Mabalirajan; Balaram Ghosh; Anurag Agrawal
Journal:  EMBO J       Date:  2014-01-15       Impact factor: 11.598

9.  Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction.

Authors:  Evandro Fei Fang; Morten Scheibye-Knudsen; Lear E Brace; Henok Kassahun; Tanima SenGupta; Hilde Nilsen; James R Mitchell; Deborah L Croteau; Vilhelm A Bohr
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

Review 10.  Microtubule Destabilization Paves the Way to Parkinson's Disease.

Authors:  D Cartelli; G Cappelletti
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.